Rochester / Rixensart / Leeds / New York / Rotterdam / Brussels / Surrey / Queen / /
Company
GlaxoSmithKline Biologicals / Clinical Trials Group / PET / Gynecologic Cancer Intergroup / The RECIST Working Group / Elsevier Ltd. / Case / Schering-Plough / /
Country
Netherlands / Belgium / United States / United Kingdom / /
Currency
pence / / /
Facility
Data Centre / East Surrey Hospital / Stable Disease / Memorial Sloan Kettering Cancer Center / National Cancer Institute / Mayo Clinic / Queen’s University / EORTC Data Centre / Erasmus University Medical Center / / /
IndustryTerm
cancer therapeutics / Cancer Treatment / pharmaceutical / imaging / cooperative groups / Treatment of Cancer / repeated imaging studies / /
MedicalCondition
malignant brain tumour / ovarian cancer / solid tumours / lymphoma / cysts / pericardial effusion / breast disease / mesothelioma / prostate cancer / cancers / necrosis / Cancer / disease / patients’ malignant disease / special Solid tumours / malignant lymphoma / EUROPEAN JOURNAL OF CANCER / tumour / pleural effusion / diseases / stable disease / metastases / inflammatory / fibrosis / tumours / /
MedicalTreatment
cancer therapeutics / /
Organization
National Cancer Institute / Division of Cancer Treatment and Diagnosis / NE PD / World Health Organization / Queen’s University / Kingston / NE CR / Erasmus University Medical Center / SD PD / European Organisation for Research and Treatment of Cancer / PD CR / Memorial Sloan Kettering Cancer Center / National Cancer Institute of Canada / Data Centre / East Surrey Hospital / /
Person
Jan Bogaerts / Robert Ford / Larry Schwartz / Patrick Therasse / ray may / / /
Position
guard / Major / representative / judge / /
ProvinceOrState
New York / Connecticut / South Dakota / Ontario / /
Technology
radiation / data warehouse / X-ray / Ultrasound / MRI / simulation / PDa / drug development / /
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)